Prevention of Long Covid Syndrome

• Status: Recruiting
• Trial end date: 2024-06-02
• Target enrollment: 0
• Participant gender: All

Summary

Biofeedback equipment is classified by the Food and Drug Administration (FDA) as medical device class II and this type of equipment/treatment has shown evidence regarding stress management in post-Covid-19 syndrome.

The main objective of the study is to verify the feasibility of an HVR biofeedback training protocol in patients with long covid, and also to verify improvement induced by the technique in relation to: cognitive performance; pain perception; fatigue; quality of life; depressive and anxious symptoms

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Cagliari

Criteria

Inclusion Criteria:

• People who have contracted Covid-19 and have symptoms attributable to Long syndrome

Exclusion Criteria:

• patients with cognitive difficulties and/or diagnosis of mental retardation

• patients with severe comorbidities with the exception of anxious/depression symptoms arising in conjunction with the viral infection or long covid syndrome.